Gene Query: DUSP10

Dataset Description Geneva Score
Gene expression changes upon drug withdrawal (Mel888 cell line) 108.24
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 81.78
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 79.73
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 42.51
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 42.41
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 40.15
The pioneer factor CEBPA modulates vitamin D signaling 40.15
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 39.68
HNF1 regulates critical functions of the human epididymis epithelium. 39.68
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 36.33
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 33.4
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 32.91
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 32.79
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 32.79
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 30.97
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 30.89
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 30.86
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 30.86
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 30.67
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 30.02
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 30.02
BAF controls genome accessibility 29.12
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 28.77
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 27.75
Primary Human B-cell Temporal Response to CD40L Stimulation 26.79
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 25.46
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 25.34
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 24.74
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 24.73
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 24.73
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 24.39
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 23.77
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 23.66
Disruption of the exocyst induces podocyte loss and dysfunction 23.39
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 23.32
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 22.98
A Unique Epigenomic Landscape Defines Human Erythropoiesis 22.91
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 22.91
Tumor exosome integrins determine organotropic metastasis 22.46
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 21.79
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 21.79
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 21.78
RNAseq analysis of ESRP regulated splicing events in prostate cancer 21.75
Transcriptomic and gene ontology profiling of the human corneal cell types 21.53
Gene expression activation in CLL mediated by MSCs contact 20.45
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 20.44
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 19.94
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 19.94
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 19.85
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 19.85
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 19.39
mRNA expression profile of Lymphocytes by high-throuput sequencing 19.21
G-quadruplex structures mark human regulatory chromatin 18.75
IL-33 activates tumor stroma to promote intestinal polyposis 18.27
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 18.08
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 18.03
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 17.65
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 17.51
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 17.51
Characterization of human ILC2 subsets 17.47
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 16.95
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 16.88
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 16.87
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 16.76
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 16.15
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 15.99
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 15.82
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 15.8
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 15.78
RNA-seq of MDA-MB-231 cells with TET1 knockout 15.25
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 15.21
JunB control of keratinocyte-mediated inflammation [RNA-seq] 15.21
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 15.08
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 14.79
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 14.7
Irf9 function in immunity in mouse 14.68
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 14.68
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 14.45
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 14.08
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 14.0
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 13.27
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 12.93
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 12.28
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 12.09
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 12.07
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 11.96
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 11.96
RNA-seq of human fibroblasts after irradiation 11.8
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 11.55
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 11.46
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 11.35
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 11.33
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 11.3
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 11.24
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 11.11
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 11.09
R430: A potent inbibitor of DNA and RNA viruses 10.83
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 10.8
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 10.77
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 10.69
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 10.56
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 10.56
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 10.56
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 10.54
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 10.45
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 10.35
RNA-seq analysis of BAP1-depleted uveal melanoma cells 10.24
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 10.2
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 10.2
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 10.18
Hypoxic transcriptome of SQ20B human head and neck cancer cells 10.16
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 10.08
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 10.06
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 10.03
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 10.02
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 10.02
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 10.0
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 9.94
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 9.91
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 9.87
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 9.87
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 9.84
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 9.79
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 9.78
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 9.72
Transcriptomic profiling of human peripheral blood-derived mast cells 9.72
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 9.69
Primary human trophoblast from term placenta 9.68
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 9.57
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 9.48
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 9.48
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 9.43
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 9.43
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 9.35
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 9.32
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 9.07
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 9.01
Paxillin regulates genomic networks in prostate cancer [LNCaP] 9.0
Differential expression of genes in AD169-infected MRC5. 8.98
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 8.94
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 8.65
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 8.62
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 8.62
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 8.61
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 8.61
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 8.61
RNA-sequencing in immortalized human mammary epithelial cells 8.61
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.58
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 8.56
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 8.55
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 8.55
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 8.55
The evolution of N6-methyladenosine in primates 8.37
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 8.36
Inhibition of TNBC metastasis by Gpx1 8.29
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 8.29
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 8.28
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 8.17
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.92
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.92
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 7.9
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 7.9
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 7.84
Intrahepatic MAIT cell gene expression revealed by RNA-seq 7.73
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 7.64
Global analysis of alternative splicing regulated by RBM10 7.63
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.59
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 7.59
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 7.58
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 7.58
A transcriptome dataset revealing the molecular features of breast cancer stem cells 7.53
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 7.3
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 7.21
An acquired vulnerability of drug resistant melanoma with therapeutic potential 7.21
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 7.16
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 7.15
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 7.15
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.15
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 7.14
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 7.13
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 7.11
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 7.1
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 7.1
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 7.09
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 7.05
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 7.05
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 6.96
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.92
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 6.92
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.9
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 6.9
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 6.85
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 6.8
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 6.79
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 6.76
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 6.74
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.7
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 6.66
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 6.65
Effect of nuclear IL-33 on gene expression 6.63
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 6.62
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 6.58
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 6.58
U2AF1 mutations alter splice site recognition in hematological malignancies 6.56
Gene expression changes in human melanoma cell lines compared to primary melanocytes 6.48
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.46
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 6.45
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 6.44
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 6.44
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 6.43
RNA-seq of MCF10A cells and CAF 6.37
Total RNA-Seq data from leukemic patients with complex structural variants 6.37
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 6.36
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 6.28
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 6.23
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 6.21
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 6.21
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 6.2
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 6.16
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 6.16
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 6.15
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 6.1
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 6.1
Intron retention induced by microsatellite expansions as a disease biomarker. 6.08
SLIGRL-induced gene expression changes in NHEK cells 6.08
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 6.06
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 6.06
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.06
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 6.03
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 6.03
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 6.01
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 6.01
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 5.96
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 5.93
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 5.89
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 5.88
Gene expression analysis of human liver progenitor-like cells in culture 5.86
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 5.82
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 5.81
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 5.79
RNA sequencing of matched nephrectomy samples [RNA-seq] 5.79
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 5.78
Generation of trichogenic adipose-derived stem cells by expression of three factors 5.77
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 5.75
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 5.74
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 5.74
mRNA expression profile of Lymphocytes 5.72
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 5.71
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 5.71
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 5.7
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.65
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 5.65
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 5.62
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 5.6
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 5.58
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 5.55
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 5.54
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 5.52
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 5.46
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 5.44
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 5.33
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 5.33
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 5.32
Ebola virus (EBOV) infection of ARPE-19 cells 5.32
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 5.32
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 5.32
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 5.31
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 5.27
KLF6-dependent transcription in renal cancer cells 5.18
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 5.17
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 5.17
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 5.16
Evaluating pre-clinical models for studying NASH driven HCC. 5.13
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 5.12
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 5.12
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 5.11
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 5.11
Splicing and epigenetic factors jointly regulate epidermal differentiation 5.06
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 5.02
RNA-seq of cells with TET1 knockout 4.95
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 4.95
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 4.95
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.93
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 4.88
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.86
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 4.86
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.86
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 4.85
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.79
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 4.76
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 4.72
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 4.69
Transcriptome of Stabilin-1 siRNA transfected human monocytes 4.62
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 4.54
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 4.54
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.5
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.5
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 4.45
The landscape of alternative splicing in aggressive prostate cancers 4.44
Proliferation-correlated expression 4.42
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 4.39
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 4.29
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 4.23
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 4.18
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.16
TFAP2C signalling in human fibroblasts 4.13
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 4.12
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 4.04
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 4.0
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.98
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 3.96
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.96
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 3.96
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 3.94
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 3.94
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.94
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 3.93
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 3.88
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.86
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.86
Efficient derivation of microglia-like cells from human pluripotent stem cells 3.84
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 3.82
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.79
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.77
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 3.76
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 3.74
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 3.68
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 3.62
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.5
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.45
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.45
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 3.42
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 3.4
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 3.39
Integrin signaling regulates YAP/TAZ to control skin homeostasis 3.3
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 3.26
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 3.26
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 3.23
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 3.23
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 3.23
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 3.14
Transcriptome of activated human and mouse MAIT cells 3.14
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.09
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 3.04
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 3.04
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 3.03
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 3.01
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 3.01
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 3.0
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.96
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 2.95
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 2.94
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 2.93
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.91
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 2.9
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 2.9
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.89
Transcriptional landscape changes during human embryonic stem cell derivation 2.85
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 2.85
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 2.84
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 2.83
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.83
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 2.78
The role of CFTR in islet function 2.76
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 2.75
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 2.75
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 2.73
Alagille_Nodder 2.69
RNA Seq of Alagille liver biopsies 2.69
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 2.69
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 2.68
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 2.68
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.68
Polarized B -cell functions 2.65
Modeling Human Cancer-induced Cachexia (Human) 2.64
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 2.62
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 2.62
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.61
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 2.59
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.56
Macrophage Ad5f35 M2 Challenge 2.55
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 2.47
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 2.47
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.45
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 2.42
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 2.42
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.36
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.31
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 2.3
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.29
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.29
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 2.27
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.23
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.16
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.15
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.07
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.06
MAIT cell RNA sequencing 2.05
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.99
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 1.98
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 1.98
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.94
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.92
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.9
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.89
The cytokine environment influence on human skin-derived T cells 1.87
mRNA sequencing of oropharyngeal cancer cell lines 1.85
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 1.82
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.81
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.79
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.79
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.76
p63 controls the enhancer landscape during keratinocyte differentiation 1.75
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.75
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.69
RNA seq_PDX2_SHP099 1.61
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.55
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.54
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 1.53
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.52
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.52
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 1.49
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 1.49
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.47
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.47
RNA-Seq from human ILC transitional populations 1.46
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.46
Leucegene: AML sequencing (part 6) 1.4
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 1.4
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 1.36
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 1.36
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.31
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 1.3
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.28
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.24
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.23
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 1.2
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.15
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.13
Analyses of T-ALL (COG study) 1.11
RNA sequencing of T-ALL (COG study) 1.11
Unique features and clinical importance of acute alloreactive immune responses 1.06
MARCKS and lnc-MARCKS act as inflammation regulators 1.02
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 1.0
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 1.0
Leucegene: ALL sequencing 1.0
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.94
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.94
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.93
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.91
RNA-seq of primary patient AML samples 0.91
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.9
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.89
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.87
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.87
Human Treg IFNg/IL-10 subpopulations 0.86
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 0.84
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.81
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.79
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.78
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.78
Widespread intronic polyadenylation diversifies immune cell transcriptomes 0.77
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.75
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.75
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.73
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 0.73
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.72
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 0.69
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 0.64
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 0.64
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.59
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 0.56
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 0.56
Transcriptome of EBV-infected gastric cancer cell lines 0.56
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.53
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.53
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.52
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.47
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.47
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.47
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.46
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.44
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.43
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.42
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.41
A single cell reference map for human blood and tissue T cell activation 0.34
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.25
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.22
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 0.17
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.16
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.14
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.13
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.12
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.12
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.12
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.09
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.09
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.09


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation